Convergence in medicine Oslo Life Science 15 February 2018

  • Feb. 21, 2018

    Predicting cancer evolution 

    Professor Trevor Graham, Barts Cancer Institute UK

    Watch his presentation

  • Feb. 21, 2018

    The convergence environment Personalised cancer therapies (PERCATHE) – background and the biostatistical perspectives

    Professor Arnoldo Frigessi,Institute of Basic Medical Sciences, Faculty of Medicine, director of Oslo Centre for Biostatistics and Epidemiology (OCBE), UiO/OUS

    Watch his presentation

  • Feb. 21, 2018

    The convergence environment Personalised cancer therapies (PERCATHE) – the biological perspectives

    Professor Kjetil Tasken, Director Centre for Molecular Medicine Norway (NCMM), the Faculty of Medicine, UiO. Head and Director of Institute for Cancer Research Oslo University Hospital (OUH)

    Watch his presentation

  • Feb. 21, 2018

    The convergence environment Personalised cancer therapies (PERCATHE) – the clinical perspectives

    Åslaug Helland, Professor II, Institute of Clinical Medicine, Faculty of Medicine, UiO

    Watch her presentation

  • Feb. 21, 2018

    Dr. Peter Loskill: Fraunhofer Institute for Interfacial Engineering and Biotechnology IGB, Germany

    Stem cell based microphysiological Organ-on-a-Chip systems as in vitro models of human tissue

    Watch his presentation

  • Feb. 21, 2018

    The convergence environment Organ on a chip and nano-devices (CHIP) – background and the biological perspectives

    Professor Stefan Krauss, Department of Molecular Medicine, Institute of Basic Medical Sciences, Faculty of Medicine, UiO, and Oslo University Hospital (OUS)

    Watch his presentation

  • Feb. 21, 2018

    The convergence environment Organ on a chip and nano-devices (CHIP) – the electronics perspective: Linear and non-linear electrical properties of biomaterials

    Professor Ørjan Grøttem Martinsen, Department of Physics, Faculty of Mathematics and Natural Sciences

    Watch his presentation

  • Feb. 21, 2018

    The convergence environment Organ on a chip and nano-devices (CHIP) – the clinical perspectives

    Dr. Hanne Scholtz, Division of surgery, inflammatory medicine and transplantation, OUS

    Watch her presentation

  • Feb. 21, 2018

    Preventing germline transmission of mitochondrial DNA mutations – therapeutic potential and ethical considerations

    Professor Mary Herbert, Wellcome Trust Centre for Mitochondrial Research, Institute of Genetic Medicine, Newcastle University, UK

    The recording of this talk is not available

  • Feb. 21, 2018

    The convergence environment Epigenetics and bioethics of human embryonic development  – background and the biological perspectives

    Professor II Arne Klungland, Institute of Basic Medical Sciences, Faculty of Medicine, UiO, and Clinic for Laboratory Medicine (KLM), Oslo University Hospital (OUS)

    Watch his presentation

  • Feb. 21, 2018

    The convergence environment Epigenetics and bioethics of human embryonic development –  the ethical perspectives

    Associate Professor, Anna Smajor, Department of Philosophy, Classics, History of Art and Ideas, Faculty of Humanities, UiO

    Watch her presentation

  • Feb. 21, 2018

    The convergence environment Epigenetics and bioethics of human embryonic development – the clinical perspectives

    Professor II, Péter Fedorcsák, Institute of Clinical Medicine, Faculty of Medicine, UiO, and Department of Reproductive Medicine, OUS

    Watch his presentation